— Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected.
— Revenue increased 5% to $39.7 billion vs. $39.43 billion expected.
— GAAP EPS attributable to the company decreased to $0.75 from $0.93 in the second quarter of 2019.
— For FY20, Cardinal Health lifted non-GAAP EPS attributable to the company outlook to a range of $5.20 to $5.40 from the previous range of $4.85 to $5.10.
— Pharmaceutical segment revenue increased 6% year-over-year to $35.7 billion.
— Medical segment revenue was flat with prior-year-quarter at $4 billion.
— CAH stock rose about 6% in the pre-market trading session.
Most Popular
ULTA Earnings: Highlights of Ulta Beauty’s Q4 2024 results
Ulta Beauty, Inc. (NASDAQ: ULTA), a leading retailer of cosmetics and personal care products, on Thursday reported a decrease in net sales for the fourth quarter of 2024. Fourth-quarter net
Key takeaways from Dollar General’s (DG) Q4 2024 earnings report
Shares of Dollar General Corporation (NYSE: DG) gained 5% on Thursday, following the company’s release of its fourth quarter 2024 earnings results. The discount store delivered a mixed performance for
DG Earnings: All you need to know about Dollar General’s Q4 2024 earnings results
Dollar General Corporation (NYSE: DG) reported its fourth quarter 2024 earnings results today. Net sales increased 4.5% year-over-year to $10.3 billion. Same-store sales increased 1.2%. Net income of $191.2 million was
